Literature DB >> 22292659

Simplified MSI marker panel for diagnosis of colorectal cancer.

Atena Irani Shemirani1, Mahdi Montazer Haghighi, Saman Milani Zadeh, Seyed Reza Fatemi, Mohammah Yaghoob Taleghani, Narges Zali, Zahra Akbari, Seyed Mohammad Hossein Kashfi, Mohammad Reza Zali.   

Abstract

BACKGROUND: Colorectal cancers (CRCs) tumors are diagnosed by microsatellite instability (MSI) due to accumulation of insertion/deletion mutations in tandem repeats of short DNA motifs (1-6 bp) called microsatellites. Microsatellite instability (MSI) is not only a hallmark marker for screening of hereditary nonpolyposis colorectal cancer (HNPCC), but also a prognostic and predictive marker for sporadic colorectal cancer. Our objective was to determine and study of five mononucleotide microsatellite markers status among Iranian patients with HNPCC and sporadic colorectal cancer.
MATERIALS AND METHODS: In the current investigation 80 sporadic CRC and 80 HNPCC patients were evaluated for MSI. The pentaplex panel including 5 quasimonomorphic mononucleotide repeats (NR-21, BAT-26, BAT-25, NR-27 and NR-24) was used.
RESULTS: Our findings showed that the NR-21 was the most frequent instable marker among the other markers. 53% and 25.6% specimens had instability in sporadic CRC and HNPCC, respectively. Furthermore, the frequencies of instability BAT-25 was determined in 20% sporadic CRC and 23% HNPCC samples. Interestingly our results demonstrated that the frequency of instability NR-24 was similar 20% sporadic CRC and 20.5% HNPCC. Moreover, percentage of NR-27 in HNPCC was 19.2 and 0% in sporadic CRC. Finally, BAT-26 was instable in 21.8% HNPCC patients while we could find 6.6% instability for BAT-26 in sporadic cases.
CONCLUSION: It seems that among 5 mononucleotides markers NR-21 was the most useful marker for diagnosis HNPCC and sporadic cancer. Following NR-21, BAT-25 and NR-24 are the most reliable markers. Therefore using a triplex panel including 3 aforementioned MSI markers should be more promising markers for identifying MSI status in both patients with HNPCC and/or sporadic colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22292659

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.

Authors:  Mehrdad Zeinalian; Mohammad Hassan Emami; Rasoul Salehi; Azar Naimi; Mohammad Kazemi; Morteza Hashemzadeh-Chaleshtori
Journal:  J Gastrointest Cancer       Date:  2015-06

2.  Deterministic Role of CEA and MSI Status in Predicting Outcome of CRC Patients: a Perspective Study Amongst Hospital Attending Eastern Indian Populations.

Authors:  Banerjee Koyel; Das Priyabrata; Bhattacharya Rittwika; Dasgupta Swati; Mukhopadhyay Soma; Basak Jayasri; Mukhopadhyay Ashis
Journal:  Indian J Surg Oncol       Date:  2017-04-08

3.  Microsatellite instability and survival in gastric cancer: A systematic review and meta-analysis.

Authors:  Lin Zhu; Zhi Li; Yan Wang; Chenlu Zhang; Yunpeng Liu; Xiujuan Qu
Journal:  Mol Clin Oncol       Date:  2015-02-06

4.  Prognostic Significance of Nuclear β-Catenin Expression in Patients with Colorectal Cancer from Iran.

Authors:  Ehsan Nazemalhosseini Mojarad; Seyed Mohammad Hossein Kashfi; Hanieh Mirtalebi; Shohre Almasi; Vahid Chaleshi; Roya Kishani Farahani; Peyman Tarban; Mahsa Molaei; Mohammad Reza Zali; Peter J K Kuppen
Journal:  Iran Red Crescent Med J       Date:  2015-07-22       Impact factor: 0.611

Review 5.  Colorectal cancer in iran: molecular epidemiology and screening strategies.

Authors:  Roya Dolatkhah; Mohammad Hossein Somi; Mortaza Jabbarpour Bonyadi; Iraj Asvadi Kermani; Faris Farassati; Saeed Dastgiri
Journal:  J Cancer Epidemiol       Date:  2015-01-15

Review 6.  Colorectal Cancer Immunotherapy: Options and Strategies.

Authors:  Nor Adzimah Johdi; Nur Fazilah Sukor
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

7.  Polymorphism of SMAD7 gene (rs2337104) and risk of colorectal cancer in an Iranian population: a case-control study.

Authors:  Zahra Akbari; Nahid Safari-Alighiarloo; Mohammad Yaghoob Taleghani; Farzaneh Sadat Mirfakhar; Hamid Asadzadeh Aghdaei; Mohsen Vahedi; Atena Irani Shemirani; Ehsan Nazemalhosseini-Mojarad; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014

8.  Low Level of Microsatellite Instability Correlates with Poor Clinical Prognosis in Stage II Colorectal Cancer Patients.

Authors:  Ehsan Nazemalhosseini Mojarad; Seyed Mohammad Hossein Kashfi; Hanieh Mirtalebi; Mohammad Yaghoob Taleghani; Pedram Azimzadeh; Sanaz Savabkar; Mohammad Amin Pourhoseingholi; Hasan Jalaeikhoo; Hamid Asadzadeh Aghdaei; Peter J K Kuppen; Mohammad Reza Zali
Journal:  J Oncol       Date:  2016-06-27       Impact factor: 4.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.